Literature DB >> 29767505

Tuned Density of Anti-Tissue Factor Antibody Fragment onto siRNA-Loaded Polyion Complex Micelles for Optimizing Targetability into Pancreatic Cancer Cells.

Hyun Su Min1, Hyun Jin Kim2, Jooyeon Ahn1, Mitsuru Naito2, Kotaro Hayashi3, Kazuko Toh3, Beob Soo Kim1, Yasuhiro Matsumura4, Ick Chan Kwon5, Kanjiro Miyata1, Kazunori Kataoka3,6.   

Abstract

Antibody fragment (Fab')-installed polyion complex (PIC) micelles were constructed to improve targetability of small interfering RNA (siRNA) delivery to pancreatic cancer cells. To this end, we synthesized a block copolymer of azide-functionalized poly(ethylene glycol) and poly(l-lysine) and prepared PIC micelles with siRNA. Then, a dibenzylcyclooctyne (DBCO)-modified antihuman tissue factor (TF) Fab' was conjugated to azido groups on the micellar surface. A fluorescence correlation spectroscopic analysis revealed that 1, 2, or 3 molecule(s) of Fab'(s) were installed onto one micellar nanoparticle according to the feeding ratio of Fab' (or DBCO) to micelle (or azide). The resulting micelles exhibited ∼40 nm in hydrodynamic diameter, similar to that of the parent micelles before Fab' conjugation. Flow cytometric analysis showed that three molecules of Fab'-installed PIC micelles (3(Fab')-micelles) had the highest binding affinity to cultured pancreatic cancer BxPC3 cells, which are known to overexpress TF on their surface. The 3(Fab')-micelles also exhibited the most efficient gene silencing activity against polo-like kinase 1 mRNA in the cultured cancer cells. Furthermore, the 3(Fab')-micelles exhibited high penetrability and the highest cellular internalization amounts in BxPC3 spheroids compared with one or two molecule(s) of Fab'-installed PIC micelles. These results demonstrate the potential of anti-TF Fab'-installed PIC micelles for active targeting of stroma-rich pancreatic tumors.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29767505     DOI: 10.1021/acs.biomac.8b00507

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN: 1525-7797            Impact factor:   6.988


  7 in total

Review 1.  Nanoscale bioconjugates: A review of the structural attributes of drug-loaded nanocarrier conjugates for selective cancer therapy.

Authors:  Wenjie Zhang; Reza Taheri-Ledari; Fatemeh Ganjali; Fereshte Hassanzadeh Afruzi; Zoleikha Hajizadeh; Mahdi Saeidirad; Fateme Sadat Qazi; Amir Kashtiaray; Samin Sadat Sehat; Michael R Hamblin; Ali Maleki
Journal:  Heliyon       Date:  2022-06-02

2.  Collagenase Nanoparticles Enhance the Penetration of Drugs into Pancreatic Tumors.

Authors:  Assaf Zinger; Lilach Koren; Omer Adir; Maria Poley; Mohammed Alyan; Zvi Yaari; Nadav Noor; Nitzan Krinsky; Assaf Simon; Hadas Gibori; Majd Krayem; Yelena Mumblat; Shira Kasten; Sivan Ofir; Eran Fridman; Neta Milman; Michael M Lübtow; Lior Liba; Jeny Shklover; Janna Shainsky-Roitman; Yoav Binenbaum; Dov Hershkovitz; Ziv Gil; Tal Dvir; Robert Luxenhofer; Ronit Satchi-Fainaro; Avi Schroeder
Journal:  ACS Nano       Date:  2019-09-20       Impact factor: 15.881

3.  Systemic Brain Delivery of Antisense Oligonucleotides across the Blood-Brain Barrier with a Glucose-Coated Polymeric Nanocarrier.

Authors:  Hyun Su Min; Hyun Jin Kim; Mitsuru Naito; Satomi Ogura; Kazuko Toh; Kotaro Hayashi; Beob Soo Kim; Shigeto Fukushima; Yasutaka Anraku; Kanjiro Miyata; Kazunori Kataoka
Journal:  Angew Chem Int Ed Engl       Date:  2020-03-06       Impact factor: 15.336

Review 4.  Polymer nanoparticle-assisted chemotherapy of pancreatic cancer.

Authors:  Tianqi Su; Bo Yang; Tianren Gao; Tongjun Liu; Jiannan Li
Journal:  Ther Adv Med Oncol       Date:  2020-05-08       Impact factor: 8.168

Review 5.  Paving the Road for RNA Therapeutics.

Authors:  Niels Dammes; Dan Peer
Journal:  Trends Pharmacol Sci       Date:  2020-09-03       Impact factor: 14.819

Review 6.  Nanomedicine in Pancreatic Cancer: Current Status and Future Opportunities for Overcoming Therapy Resistance.

Authors:  Michelle K Greene; Michael C Johnston; Christopher J Scott
Journal:  Cancers (Basel)       Date:  2021-12-07       Impact factor: 6.639

Review 7.  Pre-Clinical and Clinical Applications of Small Interfering RNAs (siRNA) and Co-Delivery Systems for Pancreatic Cancer Therapy.

Authors:  Sepideh Mirzaei; Mohammad Hossein Gholami; Hui Li Ang; Farid Hashemi; Ali Zarrabi; Amirhossein Zabolian; Kiavash Hushmandi; Masoud Delfi; Haroon Khan; Milad Ashrafizadeh; Gautam Sethi; Alan Prem Kumar
Journal:  Cells       Date:  2021-11-29       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.